Exendin-4 differentiation of a human pancreatic duct cell line into endocrine cells

Involvement of PDX-1 and HNF3β transcription factors

Jie Zhou, Marco A. Pineyro, Xiaolin Wang, Maire E. Doyle, Josephine M. Egan

Research output: Contribution to journalArticle

Abstract

Exendin-4 (EX-4), a long acting agonist of GLP-1, induces an endocrine phenotype in Capan-1 cells. Under culture conditions which include serum, ∼10% of the cells contain insulin and glucagon. When exposed to EX-4 (0.1 Nm, up to 5 days), the number of cells containing insulin and glucagon increased to ∼40%. Western blot analysis detected a progressive increase in protein levels of glucokinase and GLUT2 over 3 days of EX-4 treatment. We explored the sequence of activation of certain transcription factors known to be essential for the beta cell phenotype: PDX-1, Beta2/NeuroD, and hepatocyte nuclear factor 3β (HNF3 β). Double immunostaining showed that PDX-1 coexisted with insulin and glucagon in EX-4-treated cells. Treatment caused an increase in PDX-1 protein levels by 24 h and induced its nuclear translocation. Beta2/NeuroD protein levels also increased progressively over 24 h. HNF3β protein level increased twofold as early as 6 h after EX-4 treatment. EMSA results indicated that EX-4 caused a 1 2-fold increase in HNF3β binding to PDX-1 promoter area II. Beta2/NeuroD protein levels progressively increased after 24 h treatment. Differentiation to insulin-producing cells was also seen when Capan-1 cells were transfected with pdx-1, with 80% of these cells expressing insulin 3 days after transfection. PDX-1 antisense totally inhibited such conversion. During the differentiation of duct cells to endocrine cells, CAMP levels (EX-4 is a ligand for the GLP-1, G-protein coupled receptor) and MAP kinase activity increased. Our results indicate that EX-4 activates adenylyl cyclase and MAP kinase which, in turn, may lead to activation of transcription factors necessary for an endocrine phenotype.

Original languageEnglish (US)
Pages (from-to)304-314
Number of pages11
JournalJournal of Cellular Physiology
Volume192
Issue number3
DOIs
StatePublished - 2002
Externally publishedYes

Fingerprint

Hepatocyte Nuclear Factor 1
Transcription Factor 3
Endocrine Cells
Pancreatic Ducts
Ducts
Cells
Cell Line
Hepatocyte Nuclear Factors
Insulin
Glucagon
Glucagon-Like Peptide 1
Phenotype
Transcription Factors
Phosphotransferases
Chemical activation
G-Protein-Coupled Receptor Kinases
Glucokinase
Proteins
exenatide
G-Protein-Coupled Receptors

ASJC Scopus subject areas

  • Clinical Biochemistry
  • Cell Biology
  • Physiology

Cite this

Exendin-4 differentiation of a human pancreatic duct cell line into endocrine cells : Involvement of PDX-1 and HNF3β transcription factors. / Zhou, Jie; Pineyro, Marco A.; Wang, Xiaolin; Doyle, Maire E.; Egan, Josephine M.

In: Journal of Cellular Physiology, Vol. 192, No. 3, 2002, p. 304-314.

Research output: Contribution to journalArticle

@article{d2cec94163a44293b660f50bceabf9cd,
title = "Exendin-4 differentiation of a human pancreatic duct cell line into endocrine cells: Involvement of PDX-1 and HNF3β transcription factors",
abstract = "Exendin-4 (EX-4), a long acting agonist of GLP-1, induces an endocrine phenotype in Capan-1 cells. Under culture conditions which include serum, ∼10{\%} of the cells contain insulin and glucagon. When exposed to EX-4 (0.1 Nm, up to 5 days), the number of cells containing insulin and glucagon increased to ∼40{\%}. Western blot analysis detected a progressive increase in protein levels of glucokinase and GLUT2 over 3 days of EX-4 treatment. We explored the sequence of activation of certain transcription factors known to be essential for the beta cell phenotype: PDX-1, Beta2/NeuroD, and hepatocyte nuclear factor 3β (HNF3 β). Double immunostaining showed that PDX-1 coexisted with insulin and glucagon in EX-4-treated cells. Treatment caused an increase in PDX-1 protein levels by 24 h and induced its nuclear translocation. Beta2/NeuroD protein levels also increased progressively over 24 h. HNF3β protein level increased twofold as early as 6 h after EX-4 treatment. EMSA results indicated that EX-4 caused a 1 2-fold increase in HNF3β binding to PDX-1 promoter area II. Beta2/NeuroD protein levels progressively increased after 24 h treatment. Differentiation to insulin-producing cells was also seen when Capan-1 cells were transfected with pdx-1, with 80{\%} of these cells expressing insulin 3 days after transfection. PDX-1 antisense totally inhibited such conversion. During the differentiation of duct cells to endocrine cells, CAMP levels (EX-4 is a ligand for the GLP-1, G-protein coupled receptor) and MAP kinase activity increased. Our results indicate that EX-4 activates adenylyl cyclase and MAP kinase which, in turn, may lead to activation of transcription factors necessary for an endocrine phenotype.",
author = "Jie Zhou and Pineyro, {Marco A.} and Xiaolin Wang and Doyle, {Maire E.} and Egan, {Josephine M.}",
year = "2002",
doi = "10.1002/jcp.10143",
language = "English (US)",
volume = "192",
pages = "304--314",
journal = "Journal of Cellular Physiology",
issn = "0021-9541",
publisher = "Wiley-Liss Inc.",
number = "3",

}

TY - JOUR

T1 - Exendin-4 differentiation of a human pancreatic duct cell line into endocrine cells

T2 - Involvement of PDX-1 and HNF3β transcription factors

AU - Zhou, Jie

AU - Pineyro, Marco A.

AU - Wang, Xiaolin

AU - Doyle, Maire E.

AU - Egan, Josephine M.

PY - 2002

Y1 - 2002

N2 - Exendin-4 (EX-4), a long acting agonist of GLP-1, induces an endocrine phenotype in Capan-1 cells. Under culture conditions which include serum, ∼10% of the cells contain insulin and glucagon. When exposed to EX-4 (0.1 Nm, up to 5 days), the number of cells containing insulin and glucagon increased to ∼40%. Western blot analysis detected a progressive increase in protein levels of glucokinase and GLUT2 over 3 days of EX-4 treatment. We explored the sequence of activation of certain transcription factors known to be essential for the beta cell phenotype: PDX-1, Beta2/NeuroD, and hepatocyte nuclear factor 3β (HNF3 β). Double immunostaining showed that PDX-1 coexisted with insulin and glucagon in EX-4-treated cells. Treatment caused an increase in PDX-1 protein levels by 24 h and induced its nuclear translocation. Beta2/NeuroD protein levels also increased progressively over 24 h. HNF3β protein level increased twofold as early as 6 h after EX-4 treatment. EMSA results indicated that EX-4 caused a 1 2-fold increase in HNF3β binding to PDX-1 promoter area II. Beta2/NeuroD protein levels progressively increased after 24 h treatment. Differentiation to insulin-producing cells was also seen when Capan-1 cells were transfected with pdx-1, with 80% of these cells expressing insulin 3 days after transfection. PDX-1 antisense totally inhibited such conversion. During the differentiation of duct cells to endocrine cells, CAMP levels (EX-4 is a ligand for the GLP-1, G-protein coupled receptor) and MAP kinase activity increased. Our results indicate that EX-4 activates adenylyl cyclase and MAP kinase which, in turn, may lead to activation of transcription factors necessary for an endocrine phenotype.

AB - Exendin-4 (EX-4), a long acting agonist of GLP-1, induces an endocrine phenotype in Capan-1 cells. Under culture conditions which include serum, ∼10% of the cells contain insulin and glucagon. When exposed to EX-4 (0.1 Nm, up to 5 days), the number of cells containing insulin and glucagon increased to ∼40%. Western blot analysis detected a progressive increase in protein levels of glucokinase and GLUT2 over 3 days of EX-4 treatment. We explored the sequence of activation of certain transcription factors known to be essential for the beta cell phenotype: PDX-1, Beta2/NeuroD, and hepatocyte nuclear factor 3β (HNF3 β). Double immunostaining showed that PDX-1 coexisted with insulin and glucagon in EX-4-treated cells. Treatment caused an increase in PDX-1 protein levels by 24 h and induced its nuclear translocation. Beta2/NeuroD protein levels also increased progressively over 24 h. HNF3β protein level increased twofold as early as 6 h after EX-4 treatment. EMSA results indicated that EX-4 caused a 1 2-fold increase in HNF3β binding to PDX-1 promoter area II. Beta2/NeuroD protein levels progressively increased after 24 h treatment. Differentiation to insulin-producing cells was also seen when Capan-1 cells were transfected with pdx-1, with 80% of these cells expressing insulin 3 days after transfection. PDX-1 antisense totally inhibited such conversion. During the differentiation of duct cells to endocrine cells, CAMP levels (EX-4 is a ligand for the GLP-1, G-protein coupled receptor) and MAP kinase activity increased. Our results indicate that EX-4 activates adenylyl cyclase and MAP kinase which, in turn, may lead to activation of transcription factors necessary for an endocrine phenotype.

UR - http://www.scopus.com/inward/record.url?scp=0036326210&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036326210&partnerID=8YFLogxK

U2 - 10.1002/jcp.10143

DO - 10.1002/jcp.10143

M3 - Article

VL - 192

SP - 304

EP - 314

JO - Journal of Cellular Physiology

JF - Journal of Cellular Physiology

SN - 0021-9541

IS - 3

ER -